New research identifies more accurate way of predicting which blood cancer patients will relapse early

A study carried out by a team of researchers from The Institute of Cancer Research, London, found that combining two types of genetic tests gives doctors a much better chance of identifying multiple myeloma patients who are at risk of early relapse.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup